| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
9911
|
83.00 | 18.3B | 3.22 | 2.79 | 2.39 | 23.7% | 12.0% | 87 | 76 | 167.35 | +76.2% | 85 | 0.11 |
|
6670
|
287.50 | 40.1B | 2.94 | 2.58 | 1.42 | 46.9% | 11.7% | 86 | 81 | 636.05 | +90.9% | 85 | 0.19 |
|
8464
|
367.50 | 107.7B | 4.01 | 3.74 | 2.44 | 47.0% | 11.2% | 86 | 83 | 658.07 | +59.3% | 88 | 0.06 |
|
2520
|
36.45 | 21.7B | 2.75 | 0.92 | 1.52 | 11.7% | 7.3% | 86 | 70 | 102.58 | +136.1% | 76 | 1.02 |
|
2101
|
31.25 | 22.5B | 1.36 | 1.50 | 1.78 | 12.4% | 8.3% | 84 | 69 | 81.29 | +120.1% | 66 | 1.09 |
|
2204
|
54.00 | 29.9B | 2.20 | 0.78 | 3.23 | 2.9% | 11.2% | 84 | 57 | 137.06 | +115.4% | 82 | 0.11 |
|
2105
|
30.90 | 100.2B | 4.23 | 1.15 | 1.36 | 8.6% | 9.1% | 84 | 64 | 76.35 | +110.3% | 82 | 0.41 |
|
2206
|
63.10 | 48.5B | 2.67 | 1.90 | 2.38 | 9.9% | 8.6% | 83 | 64 | 144.68 | +97.0% | 72 | 1.23 |
|
9945
|
28.75 | 81.5B | 0.60 | 0.49 | 3.77 | 3.1% | 7.6% | 82 | 60 | 71.79 | +112.3% | 64 | 0.38 |
|
2501
|
22.35 | 25.9B | 1.94 | 0.81 | 2.52 | 6.1% | 6.7% | 81 | 64 | 58.53 | +121.4% | 63 | 1.16 |
|
2548
|
92.90 | 31.2B | 1.97 | 1.50 | 2.54 | 9.8% | 8.2% | 80 | 65 | 223.73 | +105.6% | 64 | 1.14 |
|
1808
|
36.35 | 32.5B | 2.15 | 2.35 | 2.71 | 11.5% | 7.8% | 80 | 68 | 80.46 | +91.0% | 61 | 2.16 |
|
1736
|
126.50 | 38.4B | 2.86 | 2.80 | 2.50 | 13.3% | 9.4% | 78 | 68 | 265.14 | +82.2% | 62 | 1.24 |
|
5213
|
21.40 | 15.4B | 3.31 | 1.07 | 6.37 | 3.0% | 5.5% | 75 | 58 | 42.96 | +72.6% | 39 | 3.31 |
|
9914
|
86.20 | 25.8B | 6.25 | 1.33 | 4.13 | 5.5% | 10.5% | 73 | 58 | 150.13 | +55.6% | 79 | 0.31 |
|
2201
|
29.75 | 31.6B | 8.33 | 0.49 | 6.11 | 1.7% | 3.9% | 67 | 58 | 53.07 | +56.4% | 35 | 3.68 |
|
9921
|
104.50 | 40.6B | 16.87 | 1.19 | 3.05 | 2.9% | 9.8% | 64 | 53 | 170.01 | +47.0% | 78 | 0.43 |
|
2374
|
68.70 | 23.2B | 5.30 | 2.60 | 3.96 | 12.6% | 12.1% | 62 | 40 | 74.71 | +6.3% | 84 | 0.07 |
|
2371
|
28.05 | 57.4B | — | 1.22 | 3.72 | 2.9% | 8.4% | 62 | 47 | 36.87 | +21.7% | 71 | 0.86 |
|
2489
|
42.20 | 25.7B | 7.61 | 1.96 | 6.40 | 3.1% | 12.1% | 48 | 27 | 37.63 | -7.8% | 83 | 0.05 |
|
8932
|
112.00 | 47.8B | 15.85 | 16.08 | 9.87 | 57.1% | 12.2% | 45 | 67 | 68.85 | -28.9% | 91 | 0.24 |
|
3595
|
1,775.00 | 72.2B | 72.79 | 92.27 | 56.12 | 28.6% | 11.3% | 32 | 41 | 443.75 | -56.2% | 88 | 0.00 |
|
2540
|
49.90 | 47.1B | — | 4.07 | 51.58 | 0.5% | 8.4% | 25 | 26 | 22.96 | -27.5% | 21 | 2.87 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.